Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Beglinger, C. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome. Int. J. Clin. Pract. 56, 47–51 (2002).
Agarwal, A. et al. Small molecule inhibitors of E. coli primase, a novel bacterial target. Bioorg. Med. Chem. Lett. 17, 2807–2810 (2007).
Biswas, T., Green, K. D., Garneau-Tsodikova, S. & Tsodikov, O. V. Discovery of inhibitors of Bacillus anthracis primase DnaG. Biochemistry 52, 6905–6910 (2013).
Gajadeera, C. et al. Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG. J. Antibiot. 68, 153–157 (2015).
Sanyal, G. & Doig, P. Bacterial DNA replication enzymes as targets for antibacterial drug discovery. Expert Opin. Drug Discov. 7, 327–339 (2012).
Zhang, Y. et al. Homogenous assays for Escherichia coli DnaB-stimulated DnaG primase and DnaB helicase and their use in screening for chemical inhibitors. Anal. Biochem. 304, 174–179 (2002).
Koepsell, S. A., Larson, M. A., Frey, C. A., Hinrichs, S. H. & Griep, M. A. Staphylococcus aureus primase has higher initiation specificity, interacts with single-stranded DNA stronger, but is less stimulated by its helicase than Escherichia coli primase. Mol. Microbiol. 68, 1570–1582 (2008).
Swart, J. R. & Griep, M. A. Primer synthesis kinetics by Escherichia coli primase on single-stranded DNA templates. Biochemistry 34, 16097–16106 (1995).
Johnson, S. K., Bhattacharyya, S. & Griep, M. A. DnaB helicase stimulates primer synthesis activity on short oligonucleotide templates. Biochemistry 9, 736–744 (2000).
Shadrick, W. R., Mukherjee, S., Hanson, A. M., Sweeney, N. L. & Frick, D. N. Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry 52, 6151–6159 (2013).
Weisblum, B. & Demohn, V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J. Bacteriol. 98, 447–452 (1969).
Hobbs, J. K., Miller, K., O'Neill, A. J. & Chopra, I. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J. Antimicrob. Chemother. 62, 1003–1008 (2008).
Acknowledgements
We thank James Berger and Steven Hinrichs for bacterial strains used to produce recombinant proteins; Jim Keck and Jade Wang for helpful discussions, Karen Wassarman, for assistance with primase product fractionation; Megan Duster for assistance with bacterial susceptibility studies. For assistance with screening, we thank Gene Ananiev and the University of Wisconsin Small Molecule Screening Facility supported by University of Wisconsin Carbone Cancer Center support grant P30 CA014520.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Lacriola, C., Falk, S. & Weisblum, B. Inhibition of DNA replication in Staphylococcus aureus by tegaserod. J Antibiot 70, 918–920 (2017). https://doi.org/10.1038/ja.2017.65
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2017.65